Theragnostic imaging for radiation oncology: dose-painting by numbers (Q38475358)

3 September 2017

title

Theragnostic imaging for radiation oncology: dose-painting by numbers (English)

1 reference

3 September 2017

1 reference

Søren M Bentzen

1 reference

3 September 2017

publication date

1 February 2005

1 reference

Lancet Oncology Commission

3 September 2017

published in

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

112-117

1 reference

Molecular imaging: exploring the next frontier

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Molecular Imaging: Looking at Problems, Seeing Solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Intensity-modulated radiotherapy: current status and issues of interest

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

High-tech in radiation oncology: should there be a ceiling?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Molecular (functional) imaging for radiotherapy applications: an RTOG symposium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

BOLD MRI of human tumor oxygenation during carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Repopulation in radiation oncology: perspectives of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Nuclear medicine imaging to predict response to radiotherapy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Optimizing radiation treatment plans for lung cancer using lung perfusion information

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

On biologically conformal boost dose optimization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Quality assurance of intensity-modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Implementation of IMRT in the radiotherapy department.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Radiation-induced second cancers: the impact of 3D-CRT and IMRT

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

Acute hypoxia in tumors: implications for modifiers of radiation effects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2901737-7

7 January 2021

10.1016/S1470-2045(05)01737-7

Identifiers

DOI

1 reference

3 September 2017

1 reference